02/18/2020
4:11 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
4:09 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2020
4:07 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2020
12:16 PM | BANK OF AMERICA CORP /DE/ (Filed by)
Ligand Pharmaceuticals (Subject)
| Form SC 13G
| |
02/14/2020
6:44 AM | Ligand Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G
| |
02/13/2020
10:08 AM | Ligand Pharmaceuticals (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SC 13G/A
| |
02/12/2020
7:09 AM | Ligand Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/11/2020
3:28 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2020
11:01 AM | Ligand Pharmaceuticals (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
01/10/2020
4:10 PM | JANUS HENDERSON GROUP PLC (Filed by)
Ligand Pharmaceuticals (Subject)
| Form SC 13G
| |
01/10/2020
12:55 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2019
1:01 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
1:01 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
1:01 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2019
1:00 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2019
3:06 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2019
3:07 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2019
3:05 PM | Ligand Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/05/2019
3:05 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/16/2019
5:01 PM | Boyce Sarah (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2019
7:57 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
7:58 PM | Boyce Sarah (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/24/2019
6:11 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4/A
| |
09/23/2019
9:14 AM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2019
9:14 AM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2019
7:08 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2019
6:24 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2019
6:30 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2019
6:34 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2019
12:45 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2019
3:25 PM | Ligand Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/06/2019
4:18 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/06/2019
4:17 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
6:04 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
6:00 PM | LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/05/2019
5:56 PM | Ligand Pharmaceuticals (Issuer)
Patel Sunil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2019
1:49 PM | Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2019
6:26 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2019
5:50 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/30/2019
7:13 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/02/2019
8:50 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2019
8:49 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:51 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
5:50 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
6:16 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2019
3:11 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2019
11:15 AM | Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
5:55 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
5:54 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
5:52 PM | Gray Nancy Ryan (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
5:48 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
5:46 PM | LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2019
5:44 PM | Ligand Pharmaceuticals (Issuer)
Patel Sunil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2019
4:07 PM | Ligand Pharmaceuticals (Filer)
| Form DEFA14A
| |
06/03/2019
3:13 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/31/2019
6:29 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2019
5:27 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2019
3:28 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2019
4:36 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2019
2:54 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2019
6:57 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2019
6:56 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2019
3:09 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2019
6:55 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2019
4:27 PM | Ligand Pharmaceuticals (Filed by)
SEELOS THERAPEUTICS, INC. (Subject)
| Form SC 13G
| |
03/15/2019
1:00 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2019
12:59 PM | Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2019
12:58 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2019
9:02 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2019
3:06 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2019
4:16 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2019
3:35 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
3:35 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2019
3:25 PM | Ligand Pharmaceuticals (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
| Form SC 13G/A
| |
02/12/2019
3:27 PM | Ligand Pharmaceuticals (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SC 13G
| |
02/12/2019
10:31 AM | Ligand Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/11/2019
10:06 AM | BlackRock Inc. (Filed by)
Ligand Pharmaceuticals (Subject)
| Form SC 13G/A
| |
02/07/2019
5:19 PM | KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
02/07/2019
3:16 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2019
7:19 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2019
8:00 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2019
4:13 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/25/2019
3:32 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2019
3:31 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2019
3:31 PM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/25/2019
3:30 PM | Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2019
8:17 AM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/14/2019
8:16 AM | HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2018
7:01 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/17/2018
6:58 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2018
4:32 PM | FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2018
3:08 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K/A
| |
11/13/2018
4:03 PM | Ligand Pharmaceuticals (Filed by)
Viking Therapeutics, Inc. (Subject)
| Form SC 13D/A
| |
11/13/2018
7:52 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2018
7:13 AM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2018
4:44 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2018
11:55 AM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/12/2018
5:52 PM | Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/10/2018
3:02 PM | Ligand Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2018
3:24 PM | Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
